ESR1 and breast cancer: Breast cancer with OGCs was reported in less than 2% of all breast cancers, and correlated with estrogen receptor-positive subtype and low Ki-67 (<10%)[18], in line with our sample except Ki-67 which is a marker of intense metabolism.